Locus Cell Co., Ltd. (TPEX:6891)
Taiwan · Delayed Price · Currency is TWD 49.75
+0.80 (1.63%)
Oct 12, 2026, 1:57 PM CST
Locus Cell Market Cap
Locus Cell has a market cap or net worth of 9.98 billion as of October 12, 2026. It is the 18,273rd most valuable company in the world and the 743rd biggest in Taiwan. Its market cap has increased by 53.04% in one year.
Market Cap
9.98B
Enterprise Value
9.90B
Revenue
19.40M
Global Rank
Country Rank
#743 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since April 28, 2022, Locus Cell's market cap has increased from 9.88B to 9.98B, an increase of 0.99%. That is a compound annual growth rate of 0.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 9.98B | 73.49% |
| Dec 31, 2025 | 5.75B | 44.14% |
| Dec 31, 2024 | 3.99B | -36.67% |
| Dec 29, 2023 | 6.30B | -12.86% |
| Dec 30, 2022 | 7.23B | -26.82% |
| Apr 28, 2022 | 9.88B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lumosa Therapeutics | 13.62B |
| AP Biosciences | 12.97B |
| TWi Biotechnology | 10.32B |
| TCM Biotech International | 9.80B |
| Tanvex BioPharma | 9.00B |
| PharmaEngine | 8.22B |
| Adimmune | 8.09B |
| AnnJi Pharmaceutical | 7.85B |